The implantable cardioverter defibrillator: Its history, current psychological impact and future

Expert Review of Medical Devices

Volumn 6, Issue 1, 2009, Pages 43-50

  Matchett, Melissa ^a   Sears, Samuel F ^a,b   Hazelton, Garrett ^a   Kirian, Karian ^a   Wilson, Elynor ^c   Nekkanti, Rajasekhar ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c Pitt County Health Department   (United States)

Author keywords

Defibrilator; Device acceptance; Future of defibrator; History of defibrator; Implantable cardioverter defibrilator; Psychological adjustment

Indexed keywords

CLINICAL TRIAL; DEFIBRILLATOR; DEVICE; HEART ARRHYTHMIA; HISTORY; HUMAN; MEDICAL TECHNOLOGY; MORTALITY; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL ASPECT; TREATMENT INDICATION; UTILIZATION REVIEW;

DEFIBRILLATORS, IMPLANTABLE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 63449110399     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.6.1.43     Document Type: Review

References (72)

1. Turakhia M, Tseng ZH. Sudden cardiac death: epidemiology, mechanisms, and therapy. Curr. Probl. Cardiol. 32(9), 501-546 (2007).
2. Kenny T. The Nuts and Bolts of ICD Therapy. Blackwell Publishing, MA, USA (2006).
3. Implantable Cardioverter Defibrillator Therapy: the Engineering-Clinical Interface. Kroll MW, Lehmann MH (Eds). Kluwer Academic Publishers, MA, USA (1996).
4. Implantable Cardioverter Defibrillator. Singer I (Ed.). Futura Publishing Company, Inc., Armonk, NY, USA (1991).
5. Lown B, Axelrod P. Implanted standby defibrillators. Circulation 46(4), 637-679 (1972).
6. Cardiac pacing and ICDs (4th Edition). Ellenbogen KA, Wood MA (Eds). Blackwell Publishing, MA, USA (2005).
7. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials. Ann. Intern. Med. 138(6), 445-452 (2003).
8. Mirowski M. The automatic implantable cardioverter-defibrillator: an overview. J. Am. Coll. Cardiol. 6(2), 461-466 (1985).
9. Crisp AH, Stonehill E. Aspects of the psychological status of patients treated with cardiac pacemakers. Postgrad. Med. J. 45(525), 423-427 (1969).
10. Dlin BM, Fischer HK, Huddell B. Psychologic adaptation to pacemaker and open heart surgery. Arch. Gen. Psychiatry 19(5), 599-610 (1968).
11. Dlin BM, Winters W Jr, Fischer HK, Koch P. Psychological adaptation to pacemaker following cardiac arrest. Psychosomatics 7(2), 73-80 (1966).
12. Fricchione GL, Vlay SC. Psychiatric aspects of patients with malignant ventricular arrhythmias. Am. J. Psychiatry 143(12), 1518-1526 (1986).
13. Kowey PR. The calamity of cardioversion of conscious patients. Am. J. Cardiol. 61(13), 1106-1107 (1988).
14. Wallace RL, Sears SF Jr, Lewis TS, Griffis JT, Curtis A, Conti JB. Predictors of quality of life in long-term recipients of implantable cardioverter defibrillators. J. Cardiopulm. Rehabil. 22(4), 278-281 (2002).
15. Burke JL, Hallas CN, Clark-Carter D, White D, Connelly D. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review. Br. J. Health Psychol. 8(Pt 2), 165-178 (2003).
16. Sears SF, Conti JB, Curtis AB, Saia TL, Foote R, Wen F. Affective distress and implantable cardioverter defibrillators: cases for psychological and behavioral interventions. Pacing Clin. Electrophysiol. 22(12), 1831-1834 (1999).
17. Vlay SC, Olson LC, Fricchione GL, Friedman R. Anxiety and anger in patients with ventricular tachyarrhythmias. Responses after automatic internal cardioverter defibrillator implantation. Pacing Clin. Electrophysiol. 12(2), 366-373 (1989).
18. Lemon J, Edelman S. Psychological adaptation to ICDs and the influence of anxiety sensitivity. Psychol. Health Med. 12(2), 163-171 (2007).
19. Dougherty CM. Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator. Heart Lung 24(4), 281-291 (1995).
20. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the cardiac arrest study Hamburg (CASH). Circulation 102(7), 748-754 (2000).
21. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG patch trial. Pacing Clin. Electrophysiol. 22(9), 1305-1313 (1999).
22. Irvine J, Dorian P, Baker B et al. Quality of life in the canadian implantable defibrillator study (CIDS). Am. Heart J. 144(2), 282-289 (2002).
23. Luderitz B, Jung W, Deister A, Manz M. Patient acceptance of implantable cardioverter defibrillator devices: changing attitudes. Am. Heart J. 127(4 Pt 2), 1179-1184 (1994).
24. Neel M. Posttraumatic stress symptomatology in patients with automatic implantable cardioverter defibrillators: nature and intervention. Int. J. Emerg. Ment. Health. 2(4), 259-263 (2000).
25. Hamner M, Hunt N, Gee J, Garrell R, Monroe R. PTSD and automatic implantable cardioverter defibrillators. Psychosomatics 40(1), 82-85 (1999).
26. Shemesh E, Koren-Michowitz M, Yehuda R et al. Symptoms of posttraumatic stress disorder in patients who have had a myocardial infarction. Psychosomatics 47(3), 231-239 (2006).
27. Bilge AK, Ozben B, Demircan S, Cinar M, Yilmaz E, Adelet K. Depression and anxiety status of patients with implantable cardioverter defibrillator and precipitating factors. Pacing Clin. Electrophysiol. 29(6), 619-626 (2006).
28. Carney RM, Freedland KE. Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol. Psychiatry 54(3), 241-247 (2003).
29. Whang W, Albert CM, Sears SF et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the triggers of ventricular arrhythmias (TOVA) study. J. Am. Coll. Cardiol. 45(7), 1090-1095 (2005).
30. Luyster FS, Hughes JW, Waechter D, Josephson R. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator. Psychosom. Med. 68(5), 794-800 (2006).
31. Goodman M, Hess B. Could implantable cardioverter defibrillators provide a human model supporting the learned helplessness theory of depression? Gen. Hosp. Psychiatry 21(5), 382-385 (1999).
32. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 87(5), 488-493 (2002).
33. Pedersen SS, Denollet J. Type D personality, cardiac events, and impaired quality of life: a review. Eur. J. Cardiovasc. Prev. Rehabil. 10(4), 241-248 (2003).
34. Pedersen SS, van Domburg RT, Theuns DA, Jordaens L, Erdman RA. Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners. Psychosom. Med. 66(5), 714-719 (2004).
35. Francis J, Johnson B, Niehaus M. Quality of life in patients with implantable cardioverter defibrillators. Indian Pacing Electrophysiol. J. 6(3), 173-181 (2006).
36. Passman R, Subacius H, Ruo B et al. Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch. Intern. Med. 167(20), 2226-2232 (2007).
37. Badger JM, Morris PL. Observations of a support group for automatic implantable cardioverter-defibrillator recipients and their spouses. Heart Lung 18(3), 238-243 (1989).
38. Molchany CA, Molchany CA, Peterson KA. The psychosocial effects of support group intervention on AICD recipients and their significant others. Prog. Cardiovasc. Nurs. 9(2), 23-29 (1994).
39. Sneed NV, Finch NJ, Leman RB. The impact of device recall on patients and family members of patients with automatic implantable cardioverter defibrillators. Heart Lung 23(4), 317-322 (1994).
40. Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ. Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial. Heart 89(2), 155-160 (2003).
41. Frizelle DJ, Lewin RJ, Kaye G et al. Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: a pilot study. Br. J. Health Psychol. 9(Pt 3), 381-392 (2004).
42. Chevalier P, Cottraux J, Mollard E et al. Prevention of implantable defibrillator shocks by cognitive behavioral therapy: a pilot trial. Am. Heart J. 151(1), 191 (2006).
43. Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients' long-term adjustment to the ICD: a prospective study. Pacing Clin. Electrophysiol. 23(4 Pt 1), 450-456 (2000).
44. Pedersen SS, Van Den Broek K, Sears SF. Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. PACE 30, 1-9 (2007).
45. Sears SF, Sowell LD, Kuhl EA et al. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin. Electrophysiol. 30(7), 858-864 (2007).
46. Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the fiorida patient acceptance survey. J. Cardiovasc. Electrophysiol. 16(4), 384-390 (2005).
47. Agard A, Lofmark R, Edvardsson N, Ekman I. Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation. J. Med. Ethics 33(9), 514-518 (2007).
48. Shiyovich A, Ben Zion IZ, Plakht Y, Amit G, Grosbard A, Katz A. Sexual dysfunction, depression and quality of life in male implantable cardioverter defibrillator (ICD) recipients - with and without shock delivery. Harefuah 146(8), 594-598, 647 (2007).
49. Shea JB. Quality of life issues in patients with implantable cardioverter defibrillators: driving, occupation, and recreation. AACN Clin. Issues 15(3), 478-489 (2004).
50. Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung 33(3), 176-182 (2004).
51. Sowell LV, Kuhl EA, Sears SF et al. Device implant technique and consideration of body image: specific procedures for implantable cardioverter defibrillators in female patients. J. Womens Health (Larchmt) 15(7), 830-835 (2006).
52. Gibson DP, Kuntz KK, Levenson JL et al. Decision-making, emotional distress, and quality of life in patients affected by the recall of their implantable cardioverter defibrillator. Europace 10(5), 540-544 (2008).
53. Sears SF Jr, Conti JB. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators. Am. J. Cardiol. 98(4), 565-567 (2006).
54. Rogers EM. Diffusion of Innovations (5th Edition). Free Press, Simon & Schuster, Inc., NY, USA (2008).
55. Fenn J, Linden A. Gartner's Hype Cycle Special Report for 2005. Document G00130115. Gartner Inc., CT, USA 1-7 (2003).
56. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346(12), 877-883 (2002).
57. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352(3), 225-237 (2005).
58. Lampert R. Implantable cardioverter-defibrillator use and benefit in women. Cardiol. Rev. 15(6), 298-303 (2007).
59. Burg MM, Lampert R, Joska T, Batsford W, Jain D. Psychological traits and emotion-triggering of ICD shock-terminated arrhythmias. Psychosom. Med. 66(6), 898-902 (2004).
60. Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J. Interv. Card. Electrophysiol. 22(1), 65-70 (2008).
61. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez AF, Schulman KA. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 298(13), 1517-1524 (2007).
62. Hernandez AF, Fonarow GC, Liang L et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 298(13), 1525-1532 (2007).
63. Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Birnie DH. Infiuence of gender on ICD implantation for primary and secondary prevention of sudden cardiac death. Europace 8(12), 1054-1056 (2006).
64. Gauri AJ, Davis A, Hong T, Burke MC, Knight BP. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am. J. Med. 119(2), 167.E17-E21 (2006).
65. Stanley A, DeLia D, Cantor JC. Racial disparity and technology diffusion: the case of cardioverter defibrillator implants. J. Natl Med. Assoc. 99(3), 201-207 (1996).
66. Thomas KL, Al-Khatib SM, Kelsey 2nd et al. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of ≤35%. Am. J. Cardiol. 100(6), 924-929 (2007).
67. Groeneveld PW, Heidenreich PA, Garber AM. Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. J. Am. Coll. Cardiol. 45(1), 72-78 (2005).
68. Sowell LV, Sears SF Jr, Walker RL, Kuhl EA, Conti JB. Anxiety and marital adjustment in patients with implantable cardioverter defibrillator and their spouses. J. Cardiopulm. Rehabil. Prev. 27(1), 46-49 (2007).
69. Walker RL, Campbell KA, Sears SF et al. Women and the implantable cardioverter defibrillator: a lifespan perspective on key psychosocial issues. Clin. Cardiol. 27(10), 543-546 (2004).
70. Urizar GG Jr, Sears SF Jr, Handberg E, Conti JB. Psychosocial intervention for a geriatric patient to address fears related to implantable cardioverter defibrillator discharges. Psychosomatics 45(2), 140-144 (2004).
71. DeMaso DR, Lauretti A, Spieth L et al. Psychosocial factors and quality of life in children and adolescents with implantable cardioverter-defibrillators. Am. J. Cardiol. 93(5), 582-587 (2004).
72. Kuhl EA, Sears SF, Conti JB. Using computers to improve the psychosocial care of implantable cardioverter defibrillator recipients. Pacing Clin. Electrophysiol. 29(12), 1426-1433 (2006).